Clinical Trial Update: Can the Venus 1000 Help Clinicians Treat Patients With Severe Sepsis or Acute Heart Failure? The CVP Trial [NA]

View source ↗

Summary

This document reports an update on the CVP trial evaluating the Venus 1000 device for treating severe sepsis and acute heart failure, sponsored by Mespere Lifes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Sepsis

Drugs mentioned

• Venus 1000

Snippet

Sponsor: Mespere Lifesciences Inc. | Conditions: Severe Sepsis, Acute Heart Failure | NA | Status: UNKNOWN